Compounded Semaglutide: What It Is, Is It Safe, and How It Works

Compounded semaglutide has become one of the most widely prescribed medications in the weight loss space — accessible to millions of patients who couldn't get or afford the branded versions. Understanding what it is, how it differs from branded semaglutide, and what to look for in a provider is essential before starting.

What Is Compounded Semaglutide?

Semaglutide is the active pharmaceutical ingredient in Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management). Both are manufactured by Novo Nordisk and have been in shortage for several years.

Compounded semaglutide contains the same active molecule, but is formulated by FDA-registered compounding pharmacies (503A or 503B facilities) rather than the original manufacturer. During periods of FDA-recognized drug shortage, compounding pharmacies are permitted to prepare compounded versions.

The key distinction: the molecule is identical, but the manufacturing pathway is different.

Compounded vs. Brand Name: What's the Same

• Active ingredient: semaglutide (same molecular structure)
• Mechanism of action: GLP-1 receptor agonist
• Route of administration: subcutaneous injection (usually weekly)
• Clinical effects: appetite suppression, delayed gastric emptying, weight loss
• Contraindications: same (personal/family history of MTC, MEN2, pancreatitis)

What's Different

Quality control: Brand-name products undergo extensive FDA manufacturing oversight. Compounded products rely on the pharmacy's quality systems and state board oversight. Reputable 503B pharmacies have rigorous quality protocols, but they are not FDA-approved in the same sense.

Excipients: The inactive ingredients (preservatives, buffers) may differ between compounded and branded versions. This generally doesn't affect efficacy but is worth knowing.

Formulation: Some compounded semaglutide is formulated as semaglutide acetate or semaglutide sodium — slightly different salt forms from Ozempic/Wegovy (which use sodium). The clinical significance of this is debated; most physicians don't view it as material.

Concentration and vial size: Compounded versions are typically supplied in multi-dose vials with a provided insulin syringe, rather than the pre-filled auto-injectors used for Ozempic/Wegovy.

Is Compounded Semaglutide Safe?

The honest answer: when sourced from a reputable FDA-registered 503B pharmacy, the risk profile is low. The risks come from:

1. Poor manufacturing quality: Pharmacies that cut corners on sterility, potency testing, or quality control. This is why pharmacy selection matters.

1. Dosing errors: Compounded semaglutide is drawn from a vial with a syringe, which introduces more room for dosing error than a pre-filled pen. The dose must be calculated correctly.

1. Counterfeit products: Some unscrupulous online sellers claim to sell compounded semaglutide but are selling unregulated products of unknown origin. These products may be mislabeled or contaminated.

What to look for in a legitimate provider: - Prescriptions written by a licensed physician following a medical intake - Medication sourced from an FDA-registered 503B outsourcing facility - Certificate of analysis (COA) available for each batch - Transparent pricing and no "auto-ship" schemes that are hard to cancel - Physician follow-up and monitoring included

The Titration Protocol

Compounded semaglutide uses the same titration approach as Wegovy:

• Weeks 1–4: 0.25mg/week
• Weeks 5–8: 0.5mg/week
• Weeks 9–12: 1.0mg/week
• Weeks 13–16: 1.7mg/week
• Week 17+: 2.4mg/week (maintenance)

Titration is adjusted based on tolerance. If GI side effects are significant, most physicians will extend a lower dose tier before advancing.

What Results to Expect

Based on clinical trial data (STEP-1) and real-world experience:

• Month 1–2: Appetite suppression begins; most patients lose 4–8 lbs
• Month 3–4: Most patients see meaningful scale movement (8–15 lbs total)
• Month 6: Average 10–15% body weight reduction
• Month 12: Average 14–15% body weight reduction; some patients exceed 20%

Results vary significantly based on starting weight, adherence to protocol, diet quality, and activity level.

The Regulatory Landscape

The FDA has made clear that once Wegovy and Ozempic are no longer in shortage, compounding pharmacies will no longer be permitted to produce compounded semaglutide. The status of shortage availability changes periodically.

Patients who start on compounded semaglutide and achieve significant results may eventually need to transition to branded Wegovy as pharmacy availability shifts. Your physician can guide this transition.

Bottom Line

Compounded semaglutide — from a legitimate, licensed provider — is a real, effective medical treatment for weight loss. It contains the same active ingredient as branded Wegovy, is significantly less expensive, and has helped millions of patients access a treatment they otherwise couldn't afford or obtain.

The keys are: a real medical intake, a licensed physician, and a pharmacy you can verify.